Press

Abbott Stringham Lynch Logo

Abbott, Stringham & Lynch Announces Expansion

CAMPBELL, Calif., June 26, 2025 /PRNewswire/ — Abbott, Stringham & Lynch (ASL) is excited to announce its expansion through the launch of an India-based talent hub, ASL Global Advisors Private Limited (“ASL Global”).  Located in Hyderabad, a vibrant city known for its deep talent pool and strong professional infrastructure, ASL Global officially commenced operations on Monday, […]

Abbott, Stringham & Lynch Announces Expansion Read Post »

Press
SpotOn Logo

SpotOn Maintains its Position as #1 Restaurant POS System in G2’s Summer Report

Leading Restaurant Management System Outperforms Toast, Clover, Square and Aloha in Customer Satisfaction, Market Presence and Quality of Support  SAN FRANCISCO, June 30, 2025 /PRNewswire/ — In an industry crowded with overhyped promises and one-size-fits-all solutions, restaurant operators are making their voices heard. SpotOn, the leading restaurant management system, has been named the #1 Restaurant

SpotOn Maintains its Position as #1 Restaurant POS System in G2’s Summer Report Read Post »

Press
SIMTRA PPF Au enaufnahme 8 1 1

Simtra BioPharma Solutions Expands Halle/Westfalen, Germany Facility with the Addition of a New Production Building

HALLE (WESTFALEN), Germany, June 30, 2025 /PRNewswire/ — Simtra BioPharma Solutions announced today that it completed the construction of its new production manufacturing building at its campus in Halle, Germany. As a leader in the CDMO industry specializing in sterile injectables, Simtra is strengthening its presence across North America and Europe to meet the growing

Simtra BioPharma Solutions Expands Halle/Westfalen, Germany Facility with the Addition of a New Production Building Read Post »

Press
EmpNia Logo

EmpNia Receives FDA Clearance to Market eMotus™

Novel disposable sensor pad and software offers a simple, universal, and cost-effective solution for managing respiratory motion in image-guided radiation therapy MINNEAPOLIS, June 30, 2025 /PRNewswire/ — EmpNia™, a medical device innovator dedicated to improving precision in cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to market its

EmpNia Receives FDA Clearance to Market eMotus™ Read Post »

Press
david Petrone

MSIG USA Appoints David Petrone as Northeast Region Distribution Leader

NEW YORK, June 30, 2025 /PRNewswire/ — MSIG USA, a leading provider of specialty insurance solutions, announced today the appointment of David Petrone as Northeast region distribution leader. Petrone brings more than three decades of industry experience and will report to Joseph Fitzpatrick, head of distribution for MSIG USA. Petrone joins the company following a successful

MSIG USA Appoints David Petrone as Northeast Region Distribution Leader Read Post »

Press
The BleeqUp Ranger Eurobike 2025

BleeqUp Showcases Revolutionary AI Cycling Glasses at Eurobike 2025

FRANKFURT, Germany, June 30, 2025 /PRNewswire/ — BleeqUp, an AI-powered outdoor sports technology brand, showcased its groundbreaking BleeqUp Ranger at Eurobike 2025. Hailed as the first 4-in-1 AI cycling glasses, the BleeqUp Ranger integrates essential functionalities for cyclists and runners: protective lenses, an AI-powered POV action camera, real-time walkie-talkie communication, and supper surrounding full open-ear

BleeqUp Showcases Revolutionary AI Cycling Glasses at Eurobike 2025 Read Post »

Press
Zoomcar Logo

Zoomcar Accelerates Profit Momentum in FY25 with Record Contribution and 44% EBITDA Improvement

Host Quality, Repeat Usage, and Cost Optimization Drive Turnaround; Contribution Profit Hits $4.25M, Operating Loss Cut by 67% BANGALORE, India, June 30, 2025 /PRNewswire/ — Zoomcar Holdings, Inc. (OTCQX: ZCAR) (“Zoomcar” or “the Company”), India’s leading car-sharing marketplace, today announced financial results for its fiscal year ended March 31, 2025. Deepankar Tiwari, CEO of Zoomcar,

Zoomcar Accelerates Profit Momentum in FY25 with Record Contribution and 44% EBITDA Improvement Read Post »

Press

ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging

HOUSTON and CHICAGO, June 30, 2025 /PRNewswire/ — ARTAN Bio, a community-backed biotechnology company developing therapeutics to reverse epigenetic changes associated with aging and age-related disease, and Syenex, an open-science genetic medicines platform company, today announced a strategic collaboration to access Syenex’s precision in vivo delivery technologies, the VivoCell Platform, for ARTAN’s lead drug, ARTAN-102. Under

ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging Read Post »

Press
Scroll to Top